KalVista Pharmaceuticals (NASDAQ:KALV) Posts Quarterly Earnings Results, Misses Estimates By $0.29 EPS
KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) released its quarterly earnings data on Thursday. The specialty pharmaceutical company reported ($1.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by ($0.29), Yahoo Finance reports. KalVista Pharmaceuticals Price Performance Shares of KALV stock opened at $13.04 on Friday. The stock has a […]
More Stories
MX Player for PC: How the Android Video Player Behaves on a Desktop Screen
Most people know MX Player as the app that finally played that one weird video file their phone refused to...
Release Window for Blue Eye Samurai Season 2? Latest Updates and More
Blue Eye Samurai Season 2 is releasing soon on the most popular streaming platform, Netflix. If you are also a...
What is the Release Date for GTA 6? System Requirements and Updated Features
GTA 6 is finally arriving! After years of delays and speculation, Rockstar finally confirmed the game’s launch by the end...
Upcoming Korean Drama: 100 Days of Deception Release Date, Plot, and More
K-drama fans have been longing for a historical action-romance series. Are you also one of those fans who are desperately...
Custom Web Application Development Process: Benefits, Example, Process, and Cost
For a developing business, it sometimes becomes difficult to manage spreadsheets, teams, and SaaS tools. Are you also facing the...
Netflix’s Upcoming Documentary: A Child of My Own Release Date and More
Are you also interested in watching the real-life documentary? If yes, then this blog is for you. One of the...